Compositions and methods for inhibiting expression of the HAMP gene

Details for Australian Patent Application No. 2007299629 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Tan, Pamela; Geick, Anke; Lin, Herbert Y.; Nakayama, Tomoko

Agent FB Rice

Pub. Number AU-B-2007299629

PCT Pub. Number WO2008/036933

Priority 60/870,253 15.12.06 US; 60/846,266 21.09.06 US

Filing date 21 September 2007

Wipo publication date 27 March 2008

Acceptance publication date 8 September 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036933 Priority application(s): WO2008/036933

8 September 2011 Application Accepted

  Published as AU-B-2007299629

19 January 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 15 Dec 2011. Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 2008

10 May 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 and 16 Dec 2011 2008

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299638-Fibrillated polyolefin foam

2007299626-Apparatus and method for removing heat from high intensity light bulbs